Latest Articles
Items shown: 9
40+ Statistics About Brazil’s Medical Device Import Market Manufacturers Need to Know
Brazil is the largest medical device import market in Latin America, and it's growing faster than it was three years ago. But the countries winning share, the clinical specialties leading growth, and the risks manufacturers need to plan for have all shifted meaningfully since 2021. This article compiles 40+ statistics from Pure Global's four-year import analysis to show what the data actually says.
Indonesia's Medical Device and IVD Import Market
Indonesia's $3.28 Billion MedTech Import Market Reset: The IVD Bubble Is Over; The Surgical Boom Has Begun. The report emphasizes that the 2024 boom was not a simple recovery but a fundamental shift in market demand. The growth was overwhelmingly powered by specialties related to elective and high-acuity procedures, reflecting a move to clear surgical backlogs and a long-term government strategy to improve domestic hospital capabilities.
Leveraging Medical Device CE Marking for Faster Entry into Brazil
Medical device manufacturers sometimes shy away from Brazil as a potential market due to its cumbersome and meticulous regulatory requirements. But if you already have CE Marking, ANVISA approval is more accessible than you think. Learn how ANVISA requirements overlap with the EU MDR.
Medical Device Registration Costs and Timelines for Brazil, Mexico, and Colombia
Expanding into Brazil, Mexico, and Colombia can be a major growth driver if you understand the true costs and timelines involved. This guide shows much it costs and how long approvals really take.
Thailand's Medical Device and IVD Import Market
Thailand's $3.29 Billion MedTech Import Market Undergoes Radical Shift as Post-Pandemic Demand for Aesthetics and Elder Care Surges, New Research Reveals. An analysis of historical data from 2021 to 2024 reveals an import-driven ecosystem with a total market value fluctuating between approximately $3.15 billion and $3.29 billion annually. This market is fundamentally sustained by two long-term drivers: a rapidly aging population and a thriving medical tourism sector, both of which are amplified by the government's strategic goal to establish the nation as a global "Medical Hub."
Brazil's Medical Device and IVD Import Market
Brazil's market for imported medical technology has demonstrated exceptional growth and a significant competitive realignment, establishing itself as a critical destination for global MedTech manufacturers. The total import market surged to USD $9.33 billion in 2024, an impressive 18.0% year-over-year increase, signaling a robust and accelerating demand for advanced healthcare solutions.
Mexico’s Abbreviated Regulatory Pathway is a Game-Changer for Medical Device Market Access
Mexico’s COFEPRIS will launch its new Abbreviated Regulatory Pathway on September 1, 2025, enabling medical device and drug manufacturers to fast-track approvals by leveraging prior authorizations from trusted international regulators. The streamlined process promises 30-day evaluations, aligning Mexico more closely with global regulatory standards and offering manufacturers a faster route to market.
Mexico's Medical Device and IVD Import Market
Mexico's medical device and in-vitro diagnostic (IVD) import market is a dynamic and rapidly expanding landscape, presenting both significant opportunities and complex challenges for global manufacturers. An analysis of historical import data from 2021 to 2024 reveals a market characterized by robust overall growth, shifting competitive dynamics among global trade partners, and transformative regulatory reforms. The total value of medical device and in-vitro diagnostic (IVD) imports to Mexico surged from $6.86 billion in 2021 to $11.40 billion in 2024, marking a 12.6% increase in the final year alone.
Malaysia's Medical Device and IVD Market
The Malaysian medical device and in-vitro diagnostic (IVD) market presents a compelling, high-growth opportunity, projected to reach US$4.5 billion by 2028 with a robust compound annual growth rate (CAGR) of approximately 9%. This expansion is underpinned by strong economic fundamentals, a consistent increase in government healthcare spending—highlighted by a 10% budget increase for 2025—and a clear national strategy to modernize the healthcare sector.
Let's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us